Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Warrell, RP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 78 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Soignet, SL; Frankel, SR; Douer, D; Tallman, MS; Kantarjian, H; Calleja, E; Stone, RM; Kalaycio, M; Scheinberg, DA; Steinherz, P; Sievers, EL; Coutre, S; Dahlberg, S; Ellison, R; Warrell, RP
      United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    2. He, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
      Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

      JOURNAL OF CLINICAL INVESTIGATION
    3. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
      Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia

      BLOOD
    4. Soignet, SL; Miller, VA; Pfister, DG; Bienvenu, BJ; Ho, R; Parker, BA; Amyotte, SA; Cato, A; Warrell, RP
      Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)

      CLINICAL CANCER RESEARCH
    5. Camacho, LH; Soignet, SL; Chanel, S; Ho, R; Heller, G; Scheinberg, DA; Ellison, R; Warrell, RP
      Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide

      JOURNAL OF CLINICAL ONCOLOGY
    6. Brooks, AD; Tong, W; Benedetti, F; Kaneda, Y; Miller, V; Warrell, RP
      Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Novick, SC; Warrell, RP
      Arsenicals in hematologic cancers

      SEMINARS IN ONCOLOGY
    8. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
      Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    9. Roboz, GJ; Dias, S; Lam, G; Lane, WJ; Soignet, SL; Warrell, RP; Rafii, S
      Arsenic trioxide induces dose- and time-dependent apoptosis of endotheliumand may exert an antileukemic effect via inhibition of angiogenesis

      BLOOD
    10. Warrell, RP
      Gallium nitrate and bone metastases

      TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS
    11. Soignet, SL; Tong, WP; Hirschfeld, S; Warrell, RP
      Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    12. Warrell, RP; Pandolfi, PP
      Treatment of acute promyelocytic leukemia with arsenic trioxide - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    13. Warrell, RP
      Re: Therapeutic targeting of transcription in acute promyelocytic leukemiaby use of an inhibitor of histone deacetylase - Reply

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    14. SOIGNET SL; MASLAK P; CHEN YW; CALLEJA E; PANDOLFI PP; SCHEINBERG DA; WARRELL RP
      WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/

      Annals of oncology
    15. SOIGNET SL; BENEDETTI F; FLEISCHAUER A; PARKER BA; TRUGLIA JA; CRISP MR; WARRELL RP
      CLINICAL-STUDY OF 9-CIS RETINOIC ACID (LGD1057) IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    16. SOIGNET SL; MASLAK P; WANG ZG; JHANWAR S; CALLEJA E; DARDASHTI LJ; CORSO D; DEBLASIO A; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE

      The New England journal of medicine
    17. SOIGNET SL; MASLAK P; CHEN YW; CALLEJA E; PANDOLFI PP; SCHEINBERG DA; WARRELL RP
      COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE

      British Journal of Haematology
    18. WANG ZG; RIVI R; DELVA L; KONIG A; SCHEINBERG DA; GAMBACORTIPASSERINI C; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML-RAR-ALPHA INDEPENDENT MANNER

      Blood
    19. WARRELL RP; HE LZ; RICHON V; CALLEJA E; PANDOLFI PP
      THERAPEUTIC TARGETING OF TRANSCRIPTION IN ACUTE PROMYELOCYTIC LEUKEMIA BY USE OF AN INHIBITOR OF HISTONE DEACETYLASE

      Journal of the National Cancer Institute
    20. NIESVIZKY R; WARRELL RP
      PATHOPHYSIOLOGY AND MANAGEMENT OF BONE-DISEASE IN MULTIPLE-MYELOMA

      Cancer investigation
    21. MILLER VA; BENEDETTI FM; RIGAS JR; VERRET AL; PFISTER DG; STRAUS D; KRIS MG; CRISP M; HEYMAN R; LOEWEN GR; TRUGLIA JA; WARRELL RP
      INITIAL CLINICAL-TRIAL OF A SELECTIVE RETINOID-X RECEPTOR-LIGAND, LGD1069

      Journal of clinical oncology
    22. SOIGNET S; FLEISCHAUER A; POLYAK T; HELLER G; WARRELL RP
      ALL-TRANS-RETINOIC ACID SIGNIFICANTLY INCREASES 5-YEAR SURVIVAL IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - LONG-TERM FOLLOW-UP OF THE NEW-YORK STUDY

      Cancer chemotherapy and pharmacology
    23. WARRELL RP
      CLINICAL AND MOLECULAR ASPECTS OF RETINOID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA

      International journal of cancer
    24. WARRELL RP
      GALLIUM NITRATE FOR THE TREATMENT OF BONE METASTASES

      Cancer
    25. KONIG A; WRAZEL L; WARRELL RP; RIVI R; PANDOLFI PP; JAKUBOWSKI A; GABRILOVE JL
      COMPARATIVE ACTIVITY OF MELARSOPROL AND ARSENIC TRIOXIDE IN CHRONIC B-CELL LEUKEMIA LINES

      Blood
    26. HE LZ; PERUZZI D; TRIBIOLI C; WARRELL RP; PANDOLFI PP
      THERAPEUTIC TRIALS WITH RETINOIC ACID AND ARSENIC TRIOXIDE (ASO3) IN PML-RAR-ALPHA AND PLZF-RAR-ALPHA TRANSGENIC MICE AS MODELS OF APL

      Blood
    27. WANG ZG; RIVI R; DELVA L; KONIG A; SOIGNET S; SCHEINBERG D; GAMBACORTIPASSERINI C; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/

      Blood
    28. JURCIC JG; DEBLASIO A; DUMONT L; WARRELL RP; SCHEINBERG DA
      MOLECULAR REMISSION INDUCTION WITHOUT RELAPSE AFTER ANTI-CD33 MONOCLONAL-ANTIBODY HUM195 IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      Blood
    29. SOIGNET SL; RIVI R; KONIG A; TONG WP; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      MELARSOPROL, AN ORGANIC ARSENICAL, IN THE TREATMENT OF REFRACTORY LEUKEMIA - LABORATORY AND CLINICAL-RESULTS

      Blood
    30. MILLER VA; RIGAS JR; BENEDETTI FM; VERRET AL; TONG WP; KRIS MG; GILL GM; LOEWEN GR; TRUGLIA JA; ULM EH; WARRELL RP
      INITIAL CLINICAL-TRIAL OF THE RETINOID RECEPTOR PAN AGONIST 9-CIS RETINOIC ACID

      Clinical cancer research
    31. FLOMBAUM CD; ISAACS M; REICH L; BERMAN E; WARRELL RP
      ACUTE-RENAL-FAILURE ASSOCIATED WITH THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA

      American journal of kidney diseases
    32. WARRELL RP
      PATHOGENESIS IS AND MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

      Annual review of medicine
    33. RIGAS JR; MILLER VA; ZHANG ZF; KLIMSTRA DS; TONG WP; KRIS MG; WARRELL RP
      METABOLIC PHENOTYPES OF RETINOIC ACID AND THE RISK OF LUNG-CANCER

      Cancer research
    34. RIVI R; CALLEJA E; KONIG A; LAI L; GAMBACORTIPASSERINI C; SCHEINBERG D; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ORGANIC ARSENICAL MELARSOPROL SHOWS GROWTH SUPPRESSIVE ACTIVITY VIA PROGRAMMED CELL-DEATH ON APL AND OTHER MYELOID AND LYMPHOID LEUKEMIA-DERIVED CELL-LINES

      Blood
    35. SOIGNET S; TONG WP; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      INITIAL CLINICAL-STUDY OF A NOVEL ORGANIC ARSENICAL, MELARSOPROL, IN PATIENTS WITH ADVANCED LEUKEMIA

      Blood
    36. PERUZZI D; DEBLASIO T; WARRELL RP; PANDOLFI PP
      HIGHLY SENSITIVE RT-PCR ASSAY FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    37. KONIG A; WRAZEL L; WARRELL RP; PANDOLFI PP; RIVI R; ALKATIB A; GABRILOVE JL
      IN-VITRO EFFECTS OF MELARSOPROL AS COMPARED TO ARSENIC TRIOXIDE (AS2O3) IN CHRONIC LYMPHOID MALIGNANCIES

      Blood
    38. JURCIC JG; MILLER WH; DEBLASIO A; SCHEINBERG DA; WARRELL RP
      PROGNOSTIC-SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE DETECTION AND PMLRAR-ALPHA ISOFORM TYPE - LONG-TERM FOLLOW-UP IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)/

      Blood
    39. VYAS RC; FRANKEL SR; AGBOR P; MILLER WH; WARRELL RP; HITTELMAN WN
      PROBING THE PATHOBIOLOGY OF RESPONSE TO ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - PREMATURE CHROMOSOME CONDENSATION FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS

      Blood
    40. RIGAS JR; FRANCIS PA; MILLER VA; TONG WP; ROISTACHER N; KRIS MG; ORAZEM JP; YOUNG CW; WARRELL RP
      CLINICAL AND PHARMACOLOGY STUDY OF CHLOROQUINOXALINE SULFONAMIDE GIVEN ON A WEEKLY SCHEDULE

      Cancer chemotherapy and pharmacology
    41. JURCIC JG; CARON PC; NIKULA TK; PAPADOPOULOS EB; FINN RD; GANSOW OA; MILLER WH; GEERLINGS MW; WARRELL RP; LARSON SM; SCHEINBERG DA
      RADIOLABELED ANTI-CD33 MONOCLONAL-ANTIBODY M195 FOR MYELOID LEUKEMIAS

      Cancer research
    42. WEISS M; WARRELL RP
      2 CASES OF EXTRAMEDULLARY ACUTE PROMYELOCYTIC LEUKEMIA - REPLY

      Cancer
    43. NIESVIZKY R; SIEGEL DS; BUSQUETS X; NICHOLS G; MUINDI J; WARRELL RP; MICHAELI J
      HYPERCALCEMIA AND INCREASED SERUM INTERLEUKIN-6 LEVELS INDUCED BY ALL-TRANS-RETINOIC ACID IN PATIENTS WITH MULTIPLE-MYELOMA

      British Journal of Haematology
    44. DYCK JA; WARRELL RP; EVANS RM; MILLER WH
      RAPID DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA BY IMMUNOHISTOCHEMICAL LOCALIZATION OF PML RAR-ALPHA PROTEIN/

      Blood
    45. JURCIC JG; CARON PC; DEBLASIO A; DUMONT L; WARRELL RP; SCHEINBERG DA
      TARGETED THERAPY WITH HUMANIZED ANTI-CD33 MONOCLONAL-ANTIBODY (HUM195) REDUCES RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    46. MILLER WH; JAKUBOWSKI A; TONG WP; MILLER VA; RIGAS JR; BENEDETTI F; GILL GM; TRUGLIA JA; ULM E; SHIRLEY M; WARRELL RP
      9-CIS RETINOIC ACID INDUCES COMPLETE REMISSION BUT DOES NOT REVERSE CLINICALLY ACQUIRED RETINOID RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    47. WARRELL RP; MASLAK P; EARDLEY A; HELLER G; MILLER WH; FRANKEL SR
      TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ALL-TRANS-RETINOIC ACID - AN UPDATE OF THE NEW-YORK EXPERIENCE

      Leukemia
    48. EARDLEY AM; HELLER G; WARRELL RP
      MORBIDITY AND COSTS OF REMISSION INDUCTION THERAPY WITH ALL-TRANS-RETINOIC ACID COMPARED WITH STANDARD CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    49. MUINDI JRF; YOUNG CW; WARRELL RP
      CLINICAL-PHARMACOLOGY OF ALL-TRANS-RETINOIC ACID

      Leukemia
    50. MUINDI JRF; YOUNG CW; WARRELL RP
      CLINICAL-PHARMACOLOGY OF ALL-TRANS-RETINOIC ACID

      Leukemia
    51. WARRELL RP; MASLAK P; EARDLEY A; HELLER G; MILLER WH; FRANKEL SR
      TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ALL-TRANS-RETINOIC ACID - AN UPDATE OF THE NEW-YORK EXPERIENCE

      Leukemia
    52. WARRELL RP
      THE STANDARD OF CARE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    53. WONG ET; VAHDAT L; TUNKEL RS; WILE MJ; ROSENBLUM M; WARRELL RP; FOLEY KM
      SEVERE MOTOR WEAKNESS FROM HIGH-DOSE 2-CHLORODEOXYADENOSINE

      Annals of neurology
    54. MILLER VA; RIGAS JR; MUINDI JRF; TONG WP; VENKATRAMAN E; KRIS MG; WARRELL RP
      MODULATION OF ALL-TRANS-RETINOIC ACID PHARMACOKINETICS BY LIAROZOLE

      Cancer chemotherapy and pharmacology
    55. BENEDETTI F; MILLER V; RIGAS J; TONG W; JAKUBOWSKI A; SHIRLEY M; ULM E; TRUGLIA J; GILL G; WARRELL RP
      INITIAL CLINICAL AND PHARMACOLOGICAL EVALUATION OF THE RETINOID RECEPTOR PAN-AGONIST, 9-CIS RETINOIC ACID (LGD-1057)

      Experimental hematology
    56. WARRELL RP
      APPLICATIONS FOR RETINOIDS IN CANCER-THERAPY - INTRODUCTION

      Seminars in hematology
    57. WARRELL RP; DEGOS L
      ACUTE PROMYELOCYTIC LEUKEMIA - REPLY

      The New England journal of medicine
    58. MUINDI JF; SCHER HI; RIGAS JR; WARRELL RP; YOUNG CW
      ELEVATED PLASMA-LIPID PEROXIDE CONTENT CORRELATES WITH RAPID PLASMA-CLEARANCE OF ALL-TRANS-RETINOIC ACID IN PATIENTS WITH ADVANCED CANCER

      Cancer research
    59. WEISS MA; WARRELL RP
      2 CASES OF EXTRAMEDULLARY ACUTE PROMYELOCYTIC LEUKEMIA - CYTOGENETICS, MOLECULAR-BIOLOGY, AND PHENOTYPIC AND CLINICAL-STUDIES

      Cancer
    60. VAHDAT L; MASLAK P; MILLER WH; EARDLEY A; HELLER G; SCHEINBERG DA; WARRELL RP
      EARLY MORTALITY AND THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTICLEUKEMIA - IMPACT OF LEUKOCYTOSIS, LOW-DOSE CHEMOTHERAPY, PMN RAR-ALPHA ISOFORM, AND CD13 EXPRESSION IN PATIENTS TREATED WITH ALL-TRANS-RETINOIC ACID/

      Blood
    61. BENEDETTI F; MILLER V; RIGAS J; TONG W; ULM E; TRUGLIA J; GILL G; WARRELL RP
      INITIAL CLINICAL-STUDY OF 9-CIS RETINOIC ACID (LGD-1057), A RETINOID RECEPTOR PAN-AGONIST

      Blood
    62. WARRELL RP; MILLER WH; TONG WP; JAKUBOWSKI A; MILLER V; RIGAS JR; BENEDETTI F; GILL G; TRUGLIA J
      9-CIS RETINOIC (LGD1057) YIELDS SUSTAINED PLASMA DRUG CONCENTRATIONS BUT DOES NOT REVERSE CLINICALLY ACQUIRED RETINOID RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    63. MILLER WH; HELLER G; WARRELL RP
      IMPLICATIONS OF THE PML RAR-ALPHA-ISOFORM AT PRESENTATION AND DETECTION OF PML/RAR-ALPHA BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION(RT-PCR) IN REMISSION OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)/

      Blood
    64. VAHDAT L; WONG ET; WILE MJ; ROSENBLUM M; FOLEY KM; WARRELL RP
      THERAPEUTIC AND NEUROTOXIC EFFECTS OF 2-CHLORODEOXYADENOSINE IN ADULTS WITH ACUTE MYELOID-LEUKEMIA

      Blood
    65. FRANKEL SR; EARDLEY A; HELLER G; BERMAN E; MILLER WH; DMITROVSKY E; WARRELL RP
      ALL-TRANS-RETINOIC ACID FOR ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OFTHE NEW-YORK STUDY

      Annals of internal medicine
    66. NUSSBAUM SR; WARRELL RP; RUDE R; GLUSMAN J; BILEZIKIAN JP; STEWART AF; STEPANAVAGE M; SACCO JF; AVERBUCH SD; GERTZ BJ
      DOSE-RESPONSE STUDY OF ALENDRONATE SODIUM FOR THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA

      Journal of clinical oncology
    67. WARRELL RP; LOVETT D; DILMANIAN FA; SCHNEIDER R; HEELAN RT
      LOW-DOSE GALLIUM NITRATE FOR PREVENTION OF OSTEOLYSIS IN MYELOMA - RESULTS OF A PILOT RANDOMIZED STUDY

      Journal of clinical oncology
    68. WARRELL RP; CROWN JP
      RECOVERY FROM EXTREME HYPERCALCEMIA

      Lancet
    69. MUINDI JF; STEVENS YW; WARRELL RP; YOUNG CW
      INVITRO DIFFERENTIAL METABOLISM OF MERBARONE BY XANTHINE-OXIDASE AND MICROSOMAL FLAVOENZYMES - THE ROLE OF REACTIVE OXYGEN SPECIES

      Drug metabolism and disposition
    70. WARRELL RP; DETHE H; WANG ZY; DEGOS L
      ACUTE PROMYELOCYTIC LEUKEMIA

      The New England journal of medicine
    71. WARRELL RP
      RETINOID RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA - NEW MECHANISMS,STRATEGIES, AND IMPLICATIONS

      Blood
    72. MILLER WH; LEVINE K; DEBLASIO A; FRANKEL SR; DMITROVSKY E; WARRELL RP
      DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIABY A REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSAY FOR THE PML RAR-ALPHA FUSION MESSENGER-RNA

      Blood
    73. VAHDAT L; WARRELL RP
      TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS WITH 2-CHLORO-DEOXYADENOSINE

      Blood
    74. VADHAT L; EARDLEY A; HELLER G; WARRELL RP
      LEUKOCYTOSIS, THE RETINOIC ACID (RA) SYNDROME, AND EARLY MORTALITY INACUTE PROMYELOCYTIC LEUKEMIA (APL) - WHEN IS CHEMOTHERAPY NEEDED DURING REMISSION INDUCTION WITH ALL-TRANS RA

      Blood
    75. JURCIC JG; CARON PC; MILLER WH; YAO TJ; MASLAK P; FINN R; LARSON SM; WARRELL RP; SCHEINBERG DA
      I-131-LABELED ANTI-CD33 (I-131-M195) MAY PROLONG DISEASE-FREE SURVIVAL (DFS) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) AFTER REMISSIONINDUCTION WITH ALL-TRANS-RETINOIC ACID (RA)

      Blood
    76. XIAO YH; MILLER WH; WARRELL RP; DMITROVSKY E; ZELENETZ AD
      PULSED-FIELD GEL-ELECTROPHORESIS ANALYSIS OF RETINOIC ACID RECEPTOR-ALPHA AND PROMYELOCYTIC LEUKEMIA REARRANGEMENTS - DETECTION OF THE T(1517) TRANSLOCATION IN THE DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA

      The American journal of pathology
    77. RIGAS JR; FRANCIS PA; MUINDI JRF; KRIS MG; HUSELTON C; DEGRAZIA F; ORAZEM JP; YOUNG CW; WARRELL RP
      CONSTITUTIVE VARIABILITY IN THE PHARMACOKINETICS OF THE NATURAL RETINOID, ALL-TRANS-RETINOIC ACID, AND ITS MODULATION BY KETOCONAZOLE

      Journal of the National Cancer Institute
    78. MILLER WH; KAKIZUKA A; FRANKEL SR; WARRELL RP; DEBLASIO A; LEVINE K; EVANS RM; DMITROVSKY E
      REVERSE TRANSCRIPTION POLYMERASE CHAIN-REACTION FOR THE REARRANGED RETINOIC ACID RECEPTOR-ALPHA CLARIFIES DIAGNOSIS AND DETECTS MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 16:10:33